Reese David M's Form 4 filing
Amgen Inc (AMGN) · filed Feb 21, 2025
- Accession no.
- 0001127602-25-006282
- Filed
- Feb 21, 2025
- Trade date
- Feb 19-21, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $10.2M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reese David MCIK 0001748434 | Officer (EVP & Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 | Common Stock | MOption exerciseAcquired | +8,711 | $156.35 | +$1,361,964.85 | 70,858 | Direct | |
| Feb 19, 2025 | Common Stock | SSaleDisposed | −8,711 | $293.22 | −$2,554,239.42 | 62,147 | Direct | |
| Feb 21, 2025 | Common Stock | SSaleDisposed | −25,225 | $304.44 | −$7,679,499 | 36,922 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 | Common Stock | MOption exerciseDisposed | −8,711 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.